수면무호흡증 기기 시장, 산업 동향 및 세계 예측(-2035년) : 제품 유형별, 진단 기기 유형별, 치료 기기 유형별, 기도 양압 기기 유형별, 투여 경로별, 주요 지역별

Sleep Apnea Devices Market, Industry Trends & Global Forecasts, till 2035-Distribution by Product Type, Type of Diagnostic Device, Type of Therapeutic Device, Type of Positive Airway Pressure Device, Route of Administration & Key Geographical Regions

US $ 4,799 ￦ 6,684,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,748,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,762,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,069,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

수면무호흡증 기기 시장 규모는 2023년 135억 달러에 달했습니다. 이 시장은 예측 기간인 2023년부터 2035년까지 4.61%의 CAGR로 성장할 것으로 예상됩니다.

수면무호흡증후군은 수면 중 호흡이 반복적으로 중단되는 것을 특징으로 하는 심각한 수면장애입니다. 이러한 호흡 중단은 몇 분 동안 지속될 수 있습니다. 수면무호흡증은 크게 폐쇄성 수면무호흡증, 중추성 수면무호흡증, 복합형 수면무호흡증 등 세 가지 유형으로 나뉩니다. 이 중 폐쇄성 수면무호흡증과 중추성 수면무호흡증은 가장 흔한 유형으로 큰 코골이, 아침 두통, 낮 동안의 과도한 졸음, 입마름 등의 증상이 공통적으로 나타납니다.

수면무호흡증후군은 진단되지 않는 경우가 많으며, 모든 연령대의 사람들이 걸릴 수 있습니다. 비만과 과체중은 성인 수면무호흡증의 주요 원인이며, 흡연, 음주, 운동 부족, 심리적 스트레스 등 현대인의 생활습관과 관련된 요인도 수면무호흡증 유병률 증가의 한 요인으로 작용하고 있습니다. 의료계는 수면무호흡증에 대한 효과적이고 안전하며 다양한 진단 및 치료법 개발에 점점 더 많은 노력을 기울이고 있습니다. 현재 수면무호흡증 치료에는 다양한 치료 기구가 사용되고 있습니다. 수면무호흡증에 대한 부담이 증가하고 있고, 폐쇄성 수면무호흡증에 대한 첨단 의료기기 개발을 위한 연구 개발이 진행됨에 따라 수면무호흡증 치료 기기 시장은 예측 기간 동안 안정적인 성장을 보일 것으로 예상됩니다.

이 보고서는 세계 수면무호흡증 기기 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 진단 기기 유형별, 치료 기기 유형별, 기도 양압 기기 유형별, 투여 경로별, 주요 지역별 동향, 시장 진출 기업 개요 등을 정리하여 전해드립니다.

목차

제1장 서문

제2장 조사 방법

제3장 경제 및 기타 프로젝트 특유의 고려사항

제4장 주요 요약

제5장 서론

제6장 수면무호흡증 진단 기기 : 시장 상황

제7장 수면무호흡증 치료 기기 : 시장 상황

제8장 수면무호흡증 치료제 : 시장 개요

제9장 기업 개요 : 수면무호흡증 진단 기기 개발자

• 분석 개요
• Cadwell
• Itamar Medical
• Nox Medical
• Other Leading Diagnostic Device Developers

제10장 기업 개요 : 수면무호흡증 치료 기기 개발자

• 분석 개요
• Lowenstein Medical
• ResMed
• SomnoMed
• Other Leading Therapeutic Device Developers

제11장 기업 개요 : 수면무호흡증 약물요법 개발자

• 분석 개요
• Apnimed
• Desitin Pharma
• Incannex Healthcare
• Other Leading Drug Therapy Developers

제12장 임상시험 분석

• 분석 개요
• 범위와 조사 방법
• 수면무호흡증 : 임상시험 분석

제13장 파트너십과 협업

제14장 자금 조달과 투자 분석

제15장 특허 분석

제16장 시장에 대한 영향 분석 : 촉진요인, 억제요인, 기회, 과제

• 분석 개요
• 시장 촉진요인
• 시장 억제요인
• 시장 기회
• 시장 과제
• 결론

제17장 세계의 수면무호흡증 시장

제18장 세계의 수면무호흡증 시장, 제품 유형별

제19장 세계의 수면무호흡증 진단 기기 시장

제20장 수면무호흡증 진단 기기 시장 : 진단 기기 유형별

제21장 수면무호흡증 진단 기기 시장 : 주요 지역별

제22장 세계의 수면무호흡증 치료 기기 시장

제23장 수면무호흡증 치료 기기 시장 : 치료 기기 유형별

제24장 수면무호흡증 치료 기기 시장 : PAP 기기 유형별

제25장 수면무호흡증 치료 기기 시장 : 주요 지역별

제26장 세계의 수면무호흡증 치료제 시장

제27장 수면무호흡증 치료제 시장 : 투여 경로별

제28장 수면무호흡증 치료제 시장 : 주요 지역별

제29장 결론

제30장 부록 1 : 표형식 데이터

제31장 부록 2 : 기업 및 조직 리스트

ksm

영문 목차

영문목차

Sleep Apnea Devices Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Product Type (Sleep Apnea Medical Devices and Drug Therapies), Type of Diagnostic Device (Polysomnography Devices and Home Sleep Apnea Testing Devices), Type of Therapeutic Device (Positive Airway Pressure Devices, Oral Devices and Implantable Devices), Type of Positive Airway Pressure Device (CPAP Machine, BiPAP, APAP and Other Devices), Route of Administration (Oral Therapies and Subcutaneous Therapies) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World)

The sleep apnea devices market is valued at USD 13.5 billion in 2023 growing at a CAGR of 4.61% during the forecast period 2023-2035.

Sleep apnea, also known as sleep apnea, is a serious sleep disorder characterized by repeated interruptions in breathing during sleep. These interruptions can last for several minutes. Sleep apnea is broadly classified into three types: obstructive sleep apnea, central sleep apnea, and complex sleep apnea. Among these, obstructive sleep apnea and central sleep apnea are the most common types, sharing similar symptoms such as loud snoring, morning headaches, excessive daytime sleepiness, and dry mouth.

Sleep apnea is often undiagnosed and can affect individuals of all age groups. Obesity and excess weight are identified as the leading causes of sleep apnea in adults, while modern lifestyle-related factors like smoking, alcohol consumption, lack of physical activity, and psychological stress also contribute to its increasing prevalence. Medical professionals are increasingly focused on developing effective, safe, and versatile diagnosis and treatment options for sleep apnea. Currently, various therapeutic devices are used for its treatment. Given the rising burden of sleep apnea and ongoing research efforts to develop advanced medical devices for obstructive sleep apnea, the market for sleep apnea devices is expected to witness steady growth in the forecast period.

Key Market Segments

Product Type

Sleep Apnea Medical Devices

Sleep Apnea Drug Therapies

Type of Diagnostic Device

Polysomnography Devices

Home Sleep Apnea Testing Devices

Type of Therapeutic Device

Positive Airway Pressure Devices

Oral Devices

Implantable Devices

Type of Positive Airway Pressure Device

CPAP Machine

BiPAP Machines

APAP Machines

Other Machines

Route of Administration

Oral Therapies

Subcutaneous Therapies

Key Geographical Regions

North America

Europe

Asia-Pacific

Rest of the World

Research Coverage:

The report studies the sleep apnea devices market based on product type, type of diagnostic device, type of therapeutic device, type of positive airway pressure device, route of administration and key geographical regions.

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to four major regions

A comprehensive overview of sleep apnea is presented, encompassing details on its various types and impact on health. Additionally, the discussion includes an overview of the devices utilized for both diagnosis and treatment of sleep apnea. Furthermore, information is provided on the ongoing research into drug therapies for sleep apnea.

An extensive evaluation of the overall market landscape of diagnostic devices for detecting sleep apnea is conducted, considering various pertinent parameters. These parameters include the type of device, physiological parameters monitored, type of sleep apnea diagnosed, device connectivity, target patient segment, end user and pricing. Additionally, the chapter includes information on various device developers, accompanied by an analysis based on multiple parameters such as the year of establishment, company size, and location of headquarters.

An in-depth evaluation of the overall market landscape for therapeutic devices used in the treatment of sleep apnea is conducted, taking into consideration several key parameters. These parameters include the type of sleep apnea treated, therapeutic principles employed, type of device, type of mask, type of treatment, device connectivity, storage options, target patient segment, end users, and pricing. Additionally, the chapter provides information on various device developers, accompanied by an analysis based on multiple parameters such as the year of establishment, company size, location of headquarters, and identification of the most active players in terms of the number of products developed.

A comprehensive examination of the current market landscape for drug therapies targeting sleep apnea treatment is provided, considering several key parameters. These parameters include the phase of development, type of therapy, route of administration, number of doses, and target patient segment. Additionally, the chapter presents information on various therapy developers, accompanied by an analysis based on multiple parameters such as the year of establishment, company size, and location of headquarters.

Detailed profiles of prominent companies engaged in the sleep apnea market are presented, selected based on the strength of their product portfolios. Each profile provides a concise overview of the company, including details on the year of establishment, number of employees, location of headquarters, and leadership team. Furthermore, the profiles include information on the company's product portfolio, recent developments, and an informed future outlook.

An insightful analysis of completed and ongoing clinical trials related to sleep apnea is conducted, considering various relevant parameters such as trial registration year, trial phase, trial status, type of sponsor/collaborator, study design, trial focus area, number of patients enrolled, and the most active players based on the number of clinical trials conducted. Additionally, the analysis includes geographical considerations.

An examination of partnerships within the sleep apnea market since 2017 is provided, covering various types of agreements including acquisitions, product/technology integration agreements, distribution agreements, service alliances, commercialization agreements, research agreements, and other relevant agreements.

A detailed analysis of funding and investments in sleep apnea companies since 2019 is conducted, considering various parameters such as year of investment, amount invested, type of funding, investment focus area, leading players, key investors, and geographical analysis.

An in-depth analysis of patents filed or granted related to sleep apnea since 2019 is presented, considering parameters such as the type of patent, patent publication year, patent jurisdiction, cooperative patent classification (CPC) symbols, type of applicant, leading industry players, leading non-industry players, and leading individual assignees. Additionally, the chapter includes a detailed patent benchmarking analysis and a valuation analysis highlighting leading patents based on the number of citations.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth

Key Benefits of Buying this Report

The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.

Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.

The report provides stakeholders with a pulse on the sleep apnea devices market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

Acurable

Advanced Brain Monitoring

Airway Management

Apnimed

Bayer

Belun Technology

BRAEBON Medical

Cadwell

Desitin Pharma

Drive DeVilbiss Healthcare

Eli Lilly and Company

Hunan Ventmed Medical Technology

Incannex Healthcare

Lowenstein Medical

Nihon Kohden

Nox Medical

Oventus Medical

Philips

React Health

ResMed

SciSparc

Sibelmed

Somnetics International inc

SomnoMed

Sunrise

Topson Medical

Vyaire Medical

Wellue

Whole You

ZOLL Itamar

TABLE OF CONTENTS

1. PREFACE

• 1.1. Introduction
• 1.2. Market Share Insights
• 1.3. Key Market Insights
• 1.4. Report Coverage
• 1.5 Research Methodology
• 1.6. Frequently Asked Questions
• 1.7. Chapter Outlines

2. RESEARCH METHODOLOGY

• 2.1. Chapter Overview
• 2.2. Research Assumptions
• 2.3. Project Methodology
• 2.4. Forecast Methodology
• 2.5. Robust Quality Control
• 2.6. Key Market Segmentations
• 2.7. Key Considerations
  • 2.7.1. Demographics
  • 2.7.2. Economic Factors
  • 2.7.3. Government Regulations
  • 2.7.4. Supply Chain
  • 2.7.5. COVID Impact / Related Factors
  • 2.7.6. Market Access
  • 2.7.7. Healthcare Policies
  • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

• 3.1. Chapter Overview
• 3.2. Market Dynamics
  • 3.2.1. Time Period
    • 3.2.1.1. Historical Trends
    • 3.2.1.2. Current and Future Estimates
  • 3.2.2. Currency Coverage
    • 3.2.2.1. Overview of Major Currencies Affecting the Market
    • 3.2.2.2. Impact of Currency Fluctuations on the Industry
  • 3.2.3. Foreign Exchange Impact
    • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
    • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
  • 3.2.4. Recession
    • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
    • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
  • 3.2.5. Inflation
    • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

• 5.1. Chapter Overview
• 5.2. Introduction to Sleep Apnea
• 5.3. Type of Sleep Apnea
  • 5.3.1. Obstructive Sleep Apnea
  • 5.3.2. Central Sleep Apnea
  • 5.3.3. Complex Sleep Apnea
• 5.4. The Impact of Sleep Apnea on Health
• 5.5. Diagnosis of Sleep Apnea
• 5.6. Treatment of Sleep Apnea
  • 5.6.1. Therapeutic Devices for Sleep Apnea
  • 5.6.2. Drug Therapies for Sleep Apnea
• 5.7. Concluding Remarks

6. SLEEP APNEA DIAGNOSTIC DEVICES: MARKET LANDSCAPE

• 6.1. Chapter Overview
• 6.2. Sleep Apnea Diagnostic Devices: Overall Market Landscape
  • 6.2.1. Analysis by Type of Device
  • 6.2.2. Analysis by Physiological Parameters Monitored
  • 6.2.3. Analysis by Type of Sleep Apnea Diagnosed
  • 6.2.4. Analysis by Device Connectivity
  • 6.2.5. Analysis by Target Patient Segment
  • 6.2.6. Analysis by End User
  • 6.2.7. Analysis by Price
• 6.3. Sleep Apnea Diagnostic Devices: Developer Landscape
  • 6.3.1. Analysis by Year of Establishment
  • 6.3.2. Analysis by Company Size
  • 6.3.3. Analysis by Location of Headquarters
  • 6.3.4. Analysis by Company Size and Location of Headquarters

7. SLEEP APNEA THERAPEUTIC DEVICES: MARKET LANDSCAPE

• 7.1. Chapter Overview
• 7.2. Sleep Apnea Therapeutic Devices: Overall Market Landscape
  • 7.2.1. Analysis by Type of Sleep Apnea Treated
  • 7.2.2. Analysis by Therapeutic Principle
  • 7.2.3. Analysis by Type of Device
  • 7.2.4. Analysis by Type of Mask
  • 7.2.5. Analysis by Type of Treatment
  • 7.2.6. Analysis by Device Connectivity
  • 7.2.7. Analysis by Type of Storage Offered
  • 7.2.8. Analysis by Target Patient Segment
  • 7.2.9. Analysis by End User
  • 7.2.10. Analysis by Price
• 7.3. Sleep Apnea Therapeutic Devices: Developer Landscape
  • 7.3.1. Analysis by Year of Establishment
  • 7.3.2. Analysis by Company Size
  • 7.3.3. Analysis by Location of Headquarters
  • 7.3.4. Analysis by Company Size and Location of Headquarters
  • 7.3.5. Most Active Players: Analysis by Number of Products

8. SLEEP APNEA DRUG THERAPIES: MARKET OVERVIEW

• 8.1. Chapter Overview
• 8.2. Sleep Apnea Drug Therapies: Overall Market Landscape
  • 8.2.1. Analysis by Phase of Development
  • 8.2.2. Analysis by Type of Drug Therapy
  • 8.2.3. Analysis by Route of Administration
  • 8.2.4. Analysis by Number of Doses
  • 8.2.5. Analysis by Target Patient Segment
• 8.3. Sleep Apnea: Developer Landscape (Industry Players)
  • 8.3.1. Analysis by Year of Establishment
  • 8.3.2. Analysis by Company Size
  • 8.3.3. Analysis by Location of Headquarters
  • 8.3.4. Analysis by Company Size and Location of Headquarters

9. COMPANY PROFILES: SLEEP APNEA DIAGNOSTIC DEVICE DEVELOPERS

• 9.1. Chapter Overview
• 9.2. Cadwell
  • 9.2.1. Company Overview
  • 9.2.2. Device Portfolio
  • 9.2.3. Recent Developments and Future Outlook
• 9.3. Itamar Medical
  • 9.3.1. Company Overview
  • 9.3.2. Device Portfolio
  • 9.3.3. Recent Developments and Future Outlook
• 9.4. Nox Medical
  • 9.4.1. Company Overview
  • 9.4.2. Device Portfolio
  • 9.4.3. Recent Developments and Future Outlook
• 9.5. Other Leading Diagnostic Device Developers
  • 9.5.1. Acurable
  • 9.5.2. Advanced Brain Monitoring
  • 9.5.3. Belun Technology
  • 9.5.4. Braebon Medical
  • 9.5.5. Nihon Kohden
  • 9.5.6. Sibelmed
  • 9.5.7. Sunrise
  • 9.5.8. Vyaire Medical
  • 9.5.9. Wellue

10. COMPANY PROFILES: SLEEP APNEA THERAPEUTIC DEVICE DEVELOPERS

• 10.1. Chapter Overview
• 10.2. Lowenstein Medical
  • 10.2.1. Company Overview
  • 10.2.2. Device Portfolio
  • 10.2.3. Recent Developments and Future Outlook
• 10.3. ResMed
  • 10.3.1. Company Overview
  • 10.3.2. Device Portfolio
  • 10.3.3. Recent Developments and Future Outlook
• 10.4. SomnoMed
  • 10.4.1. Company Overview
  • 10.4.2. Device Portfolio
  • 10.4.3. Recent Developments and Future Outlook
• 10.5. Other Leading Therapeutic Device Developers
  • 10.5.1. Airway Management
  • 10.5.2. Drive DeVilbiss Healthcare
  • 10.5.3. Hunan VentMed Medical Technology
  • 10.5.4. Oventus
  • 10.5.5. Philips
  • 10.5.6. React Health
  • 10.5.7. Somnetics International
  • 10.5.8. Topson Medical
  • 10.5.9. Whole You

11. COMPANY PROFILES: SLEEP APNEA DRUG THERAPY DEVELOPERS

• 11.1. Chapter Overview
• 11.2. Apnimed
  • 11.2.1. Company Overview
  • 11.2.2. Drug Therapy Portfolio
  • 11.2.3. Recent Developments and Future Outlook
• 11.3. Desitin Pharma
  • 11.3.1. Company Overview
  • 11.3.2. Drug Therapy Portfolio
  • 11.3.3. Recent Developments and Future Outlook
• 11.4. Incannex Healthcare
  • 11.4.1. Company Overview
  • 11.4.2. Drug Therapy Portfolio
  • 11.4.3. Recent Developments and Future Outlook
• 11.5. Other Leading Drug Therapy Developers
  • 11.5.1. Bayer
  • 11.5.2. Eli Lilly and Company
  • 11.5.3. SciSparc

12. CLINICAL TRIAL ANALYSIS

• 12.1. Chapter Overview
• 12.2. Scope and Methodology
• 12.3. Sleep Apnea: Clinical Trial Analysis
  • 12.3.1. Analysis by Trial Registration Year
  • 12.3.2. Analysis by Trial Phase
  • 12.3.3. Analysis by Trial Status
  • 12.3.4. Analysis by Trial Registration Year and Trial Status
  • 12.3.5. Analysis by Type of Sponsor / Collaborator
  • 12.3.6. Analysis by Study Design
    • 12.3.6.1. Analysis by Type of Patient Allocation Model Used
    • 12.3.6.2. Analysis by Type of Intervention
    • 12.3.6.3. Analysis by Type of Trial Masking Adopted
    • 12.3.6.4. Analysis by Trial Purpose
  • 12.3.7. Analysis by Trial Focus Area
  • 12.3.8. Analysis of Patients Enrolled by Trial Registration Year
  • 12.3.9. Analysis of Patients Enrolled by Trial Phase
  • 12.3.10. Most Active Industry Players: Analysis by Number of Clinical Trials
  • 12.3.11. Most Active Non-Industry Players: Analysis by Number of Clinical Trials
  • 12.3.12. Analysis of Clinical Trials by Geography
    • 12.3.12.1. Analysis of Clinical Trials by Geography and Trial Status
    • 12.3.12.2. Analysis of Patients Enrolled by Trial Status and Geography

13. PARTNERSHIPS AND COLLABORATIONS

• 13.1. Chapter Overview
• 13.2. Partnership Models
• 13.3. Sleep Apnea Therapies and Devices: Partnerships and Collaborations
  • 13.3.1. Analysis by Year of Partnership
  • 13.3.2. Analysis by Type of Partnership
  • 13.3.3. Analysis by Year and Type of Partnership
  • 13.3.4. Analysis by Type of Partner
  • 13.3.5. Most Active Players: Analysis by Number of Partnerships
  • 13.3.6. Analysis by Geography
    • 13.3.6.1. Local and International Deals
    • 13.3.6.2. Intercontinental and Intracontinental Deals

14. FUNDING AND INVESTMENT ANALYSIS

• 14.1. Chapter Overview
• 14.2. Types of Funding
• 14.3. Sleep Apnea: Funding and Investment Analysis
  • 14.3.1. Analysis by Year of Investment
  • 14.3.2. Analysis of Amount Invested by Year
  • 14.3.3. Analysis by Type of Funding
  • 14.3.4. Analysis of Amount Invested by Type of Funding
  • 14.3.5. Analysis of Amount Invested by Year and Type of Funding
  • 14.3.6. Analysis by Investment Focus Area
  • 14.3.7. Most Active Players: Analysis by Number of Instances
  • 14.3.8. Most Active Players: Analysis by Amount Raised
  • 14.3.9. Analysis by Type of Investor
  • 14.3.10. Leading Investors: Analysis by Number of Funding Instances
  • 14.3.11. Analysis by Geography
    • 14.3.11.1. Analysis of Instances by Geography
    • 14.3.11.2. Analysis of Amount Invested by Geography

15. PATENT ANALYSIS

• 15.1. Chapter Overview
• 15.2. Scope and Methodology
• 15.3. Sleep Apnea: Patent Analysis
  • 15.3.1. Analysis by Type of Patent
  • 15.3.2. Analysis by Patent Publication Year
  • 15.3.3. Analysis by Type of Patent and Patent Publication Year
  • 15.3.4. Analysis by Patent Jurisdiction
  • 15.3.5. Analysis by CPC Symbols
  • 15.3.6. Analysis by Type of Applicant
  • 15.3.7. Leading Industry Players: Analysis by Number of Patents
  • 15.3.8. Leading Non-Industry Players: Analysis by Number of Patents
  • 15.3.9. Leading Individual Assignees: Analysis by Number of Patents
• 15.4. Sleep Apnea: Patent Benchmark Analysis
  • 15.4.1. Analysis by Patent Characteristics
• 15.5. Patent Valuation Analysis

16. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 16.1. Chapter Overview
• 16.2. Market Drivers
• 16.3. Market Restraints
• 16.4. Market Opportunities
• 16.5. Market Challenges
• 16.6. Conclusion

17. GLOBAL SLEEP APNEA MARKET

• 17.1. Chapter Overview
• 17.2. Assumptions and Methodology
• 17.3. Global Sleep Apnea Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.3.1. Scenario Analysis
• 17.4. Key Market Segmentations

18. GLOBAL SLEEP APNEA MARKET BY TYPE OF PRODUCT

• 18.1. Chapter Overview
• 18.2. Assumptions and Methodology
• 18.3. Global Sleep Apnea Market: Distribution by Type of Product, 2018, 2023 and 2035
  • 18.3.1. Sleep Apnea Medical Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 18.3.2. Drug Therapies: Forecasted Estimates (2025-2035)
• 18.4. Data Triangulation and Validation

19. GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET

• 19.1. Chapter Overview
• 19.2. Assumptions and Methodology
• 19.3. Scenario 1: Global Sleep Apnea Diagnostic Devices Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 19.3.1. Scenario Analysis

20. SLEEP APNEA DIAGNOSTIC DEVICES MARKET: DISTRIBUTION BY TYPE OF DIAGNOSTIC DEVICE

• 20.1. Chapter Overview
• 20.2. Key Assumptions and Methodology
• 20.3. Sleep Apnea Diagnostic Devices Market: Distribution by Type of Diagnostic Device, 2018, 2023 and 2035
  • 20.3.1. Polysomnography Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 20.3.2. Home Sleep Apnea Testing Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 20.4. Data Triangulation and Validation

21. SLEEP APNEA DIAGNOSTIC DEVICES MARKET: DISTRIBUTION BY KEY GEOGRAPHICAL REGIONS

• 21.1. Chapter Overview
• 21.2. Key Assumptions and Methodology
• 21.3. Sleep Apnea Diagnostic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
  • 21.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 21.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 21.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 21.3.4. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 21.4. Data Triangulation and Validation

22. GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET

• 22.1. Chapter Overview
• 22.2. Assumptions and Methodology
• 22.3. Global Sleep Apnea Therapeutic Devices Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 22.3.1. Scenario Analysis

23. SLEEP APNEA THERAPEUTIC DEVICES MARKET: DISTRIBUTION BY TYPE OF THERAPEUTIC DEVICE

• 23.1. Chapter Overview
• 23.2. Key Assumptions and Methodology
• 23.3. Sleep Apnea Therapeutic Devices Market: Distribution by Type of Therapeutic Device, 2018, 2023 and 2035
  • 23.3.1. PAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 23.3.2. Oral Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 23.3.3. Implanted Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 23.4. Data Triangulation and Validation

24. SLEEP APNEA THERAPEUTIC DEVICES MARKET: DISTRIBUTION BY TYPE OF PAP DEVICE

• 24.1. Chapter Overview
• 24.2. Key Assumptions and Methodology
• 24.3. Sleep Apnea Therapeutic Devices Market: Distribution by Type of PAP Device, 2018, 2023 and 2035
  • 24.3.1. CPAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 24.3.2. BiPAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 24.3.3. APAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 24.3.4. Other Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 24.4. Data Triangulation and Validation

25. SLEEP APNEA THERAPEUTIC DEVICES MARKET: DISTRIBUTION BY KEY GEOGRAPHICAL REGIONS

• 25.1. Chapter Overview
• 25.2. Key Assumptions and Methodology
• 25.3. Sleep Apnea Therapeutic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
  • 25.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 25.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 25.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 25.3.4. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 25.4. Data Triangulation and Validation

26. GLOBAL SLEEP APNEA DRUG THERAPIES MARKET

• 26.1. Chapter Overview
• 26.2. Assumptions and Methodology
• 26.3. Global Sleep Apnea Drug Therapies Market: Forecasted Estimates (2025-2035)
  • 26.3.1. Scenario Analysis
• 26.4. Sleep Apnea Drug Therapies Market: Drug Therapy-Wise Sales Forecast, 2025-2035

27. SLEEP APNEA DRUG THERAPIES MARKET: DISTRIBUTION BY ROUTE OF ADMINISTRATION

• 27.1. Chapter Overview
• 27.2. Assumptions and Methodology
• 27.3. Sleep Apnea Drug Therapies Market: Distribution by Route of Administration, 2025 and 2035
  • 27.3.1. Oral Drug Therapies Market: Forecasted Estimates (2026-2035)
  • 27.3.2. Subcutaneous Drug Therapies Market: Forecasted Estimates (2025-2035)

28. SLEEP APNEA DRUG THERAPIES MARKET: DISTRIBUTION BY KEY GEOGRAPHICAL REGIONS

• 28.1. Chapter Overview
• 28.2. Key Assumptions and Methodology
• 28.3 Sleep Apnea Drug Therapies Market: Distribution by Key Geographical Regions, 2025 and 2035
  • 28.3.1. North America: Forecasted Estimates (2025-2035)
    • 28.3.1.1. US: Forecasted Estimates (2025-2035)
    • 28.3.1.2. Mexico: Forecasted Estimates (2025-2035)
  • 28.3.2. Europe: Forecasted Estimates (2026-2035)
    • 28.3.2.1. Belgium: Forecasted Estimates (2027-2035)
    • 28.3.2.2. Germany: Forecasted Estimates (2026-2035)
  • 28.3.3. Asia-Pacific: Forecasted Estimates (2026-2035)
    • 28.3.3.1. Australia: Forecasted Estimates (2026-2035)
    • 28.3.3.2. China: Forecasted Estimates (2026-2035)
    • 28.3.3.3. Japan: Forecasted Estimates (2026-2035)
    • 28.3.3.4. Taiwan: Forecasted Estimates (2026-2035)
  • 28.3.4. Rest of the World: Forecasted Estimates (2026-2035)
    • 28.3.4.1. Brazil: Forecasted Estimates (2026-2035)

29. CONCLUSION

30. APPENDIX 1: TABULATED DATA

31. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

관련자료